Literature DB >> 23140992

Large diameter metal on metal articulations. Comparison of total hip arthroplasty and hip resurfacing arthroplasty.

Christopher M Jack1, William L Walter, Andrew J Shimmin, Kara Cashman, Richard N de Steiger.   

Abstract

The use of large diameter metal bearing total hip arthroplasty (THA) and hip resurfacing arthroplasty (HRA) increased in popularity in the last decade. More recent literature has highlighted the effect of head size in patient outcomes. Data was obtained from the Australian Orthopaedic Association National Joint Replacement Registry (AOA-NJRR) to evaluate the Birmingham (MoM) bearing surface when used with THA and HRA. There is no difference in the overall rate of revision between the THA and HRA but head size has a significant effect on revision rate. The data show that small diameter metal bearings in HRA (below 50mm) have a higher rate of revision than large diameter metal bearings in HRA (equal to and above 50mm) (P<.001). Conversely the large diameter metal bearings in THA have a higher rate of revision than the small diameter metal bearings in THA (P=.027). The revision rate for large diameter HRA compared to small diameter THA is not significantly different P=.670. We recommend caution when choosing either a large diameter (≥50mm) metal on metal THA or small diameter (<50mm) HRA.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23140992     DOI: 10.1016/j.arth.2012.07.032

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

1.  Large-diameter metal-on-metal total hip arthroplasty: dislocation infrequent but survivorship poor.

Authors:  Adolph V Lombardi; Keith R Berend; Michael J Morris; Joanne B Adams; Michael A Sneller
Journal:  Clin Orthop Relat Res       Date:  2014-11-04       Impact factor: 4.176

2.  CORR Insights ®: Hip resurfacing does not improve proprioception compared with THA.

Authors:  Rocco P Pitto
Journal:  Clin Orthop Relat Res       Date:  2013-07-25       Impact factor: 4.176

3.  [What can we learn in future from the data of the German Arthroplasty Registry (EPRD) in comparison to other registries?].

Authors:  V Jansson; A Steinbrück; J Hassenpflug
Journal:  Unfallchirurg       Date:  2016-06       Impact factor: 1.000

4.  What causes unexplained pain in patients with metal-on metal hip devices? A retrieval, histologic, and imaging analysis.

Authors:  Danyal H Nawabi; Nader A Nassif; Huong T Do; Kirsten Stoner; Marcella Elpers; Edwin P Su; Timothy Wright; Hollis G Potter; Douglas E Padgett
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

5.  Do ion levels in metal-on-metal hip resurfacing differ from those in metal-on-metal THA at long-term followup?

Authors:  Lucia Savarino; Matteo Cadossi; Eugenio Chiarello; Nicola Baldini; Sandro Giannini
Journal:  Clin Orthop Relat Res       Date:  2013-04-10       Impact factor: 4.176

6.  Femoral diameter and stem type are independent risk factors for ARMD in the large-headed ASR THR group.

Authors:  Aleksi Reito; Petra Elo; Timo Puolakka; Jorma Pajamäki; Antti Eskelinen
Journal:  BMC Musculoskelet Disord       Date:  2015-05-15       Impact factor: 2.362

7.  No functional benefit of larger femoral heads and alternative bearings at 6 months following primary hip replacement.

Authors:  Simon S Jameson; James M Mason; Paul N Baker; Paul J Gregg; David J Deehan; Mike R Reed
Journal:  Acta Orthop       Date:  2014-10-10       Impact factor: 3.717

8.  Reducing the failure rate of hip resurfacing in dysplasia patients: a retrospective analysis of 363 cases.

Authors:  Melissa D Gaillard; Thomas P Gross
Journal:  BMC Musculoskelet Disord       Date:  2016-06-07       Impact factor: 2.362

Review 9.  Prevalence of Failure due to Adverse Reaction to Metal Debris in Modern, Medium and Large Diameter Metal-on-Metal Hip Replacements--The Effect of Novel Screening Methods: Systematic Review and Metaregression Analysis.

Authors:  Aleksi Reito; Olli Lainiala; Petra Elo; Antti Eskelinen
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.